Similarly, we also previously demonstrated that the delivery of either anti-TGF-β or IL-10 within HA improved renal fibrosis in a murine model of CKD, while in combination their delivery worsened renal fibrosis [8]. Here, TGFB1 is linked to chronic kidney disease.